Proof of mechanism for the DGAT1 inhibitor AZD7687 : results from a first‐time‐in‐human single‐dose study
Year: 2012
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12002
Institutions: AstraZeneca (Sweden), Sahlgrenska University Hospital
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: AstraZeneca
OpenAlex ID: W2101217072
